Search Results for

Clear All Filters

July 10, 2020

Press Release

Congressional Oversight

Supreme Court’s Decision in Trump v. Mazars Underscores Costs of Rep. Neal’s Delays

In a pair of decisions released this morning, the Supreme Court rejected President Trump’s claims of “absolute” immunity from criminal investigation or congressional scrutiny. The victory, however, is incomplete and underscores that Ways and Means Chairman Richard Neal’s delays in requesting Trump’s tax returns likely cost the American people dearly in terms of presidential transparency.

May 06, 2020

Jeff Hauser

Press Release

Anti-MonopolyBigLawFTCRevolving Door

RDP Bemoans Big Pharma Merger Facilitated by Revolving Door BigLaw Lawyers

Revolving Door Project Executive Director Jeff Hauser said, “This anti-competitive merger further entrenches Big Pharma at the expense of all Americans. Big Pharma’s playbook here is no less dangerous for having become rote: They hire well-connected revolving door FTC alumni to secure approval for mergers that undermine the public interest. To restore the public interest at the FTC, we will need to end the FTC-to-BigLaw pipeline that has helped bring about an economy that works well for rich investors rather than American consumers or workers.”

April 21, 2020

Jeff Hauser

Press Release

Congressional Oversight

This Time Around, Congress Must Implement Meaningful Oversight of SBA Loan Programs

Congressional leaders have finally reached a deal to replenish the SBA COVID response loan programs temporarily after days of negotiations. Putting aside the tragically narrow parameters of this deal, House Democrats should only be acceding to further funding these ill-designed programs after they have secured effective oversight of the Trump Administration’s heretofore bumbling execution of the law.